Sorafenib reverses resistance of gastric cancer to treatment by cisplatin through down-regulating MDR1 expression
Crossref DOI link: https://doi.org/10.1007/s12032-014-0470-1
Published Online: 2015-01-13
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Huang, Yi-sheng
Xue, Zhi
Zhang, Hua
Text and Data Mining valid from 2015-01-13